Maximising the value of your scientific data by 
enhancing its integrity, integration and accessibility

November 15, 2022 | Free Pharma IQ Online Event

Sylvain Demanze

Senior Analytical Scientist AstraZeneca

Analytical Scientist with over 15 years of R&D experience across Europe in the Pharmaceutical Industry. Extensive hands-on experience in the analysis, purification and characterisation of small to medium size molecules. Worked on Drug Discovery Projects in the Therapeutic Areas of Neuroscience (Neurodegeneration, Neuro-inflammation, Proteopathies), Infectious Diseases and Oncology. Global Collaborator: thrives at the interface between Medicinal/Computational Chemistry & Biology. Comfortable working in multi-disciplinary and multi-site teams Innovator: track record of delivering improvements in Lab processes and methodologies. Established in-house Analytical Expert and Advisor for a wide range of techniques. Versed in presenting or reporting back data clearly and effectively to Internal & External Customers. Experienced in the evaluation of new enabling technologies, capital planning and operational strategies. Lab Responsibilities & Technical Leadership: supervision and mentoring of junior scientists in the last 3 roles.

Tuesday, 15th November 2022 (All Times in CET)

2:00 PM Automating analytical data-driven decision making in Drug Discovery Labs

In this session Sylvain Demanze will discuss automating analytical data driven decision making, focusing on:


  • Why Automation is an absolute MUST in the pharma industry
  • Initiatives for dealing with the ever-increasing volumes of analytical data generated in the labs
  • Addressing the human-review bottlenecks in our processes by either adopting a facilitated, review-by-exception approach or even through complete removal of the required human input steps
  • Concrete examples of lab efficiency gains, as well as of “Augmented Analysis” via modern visualisation tools and data-mining enablement